GSTT1-null genotype is a protective factor against bladder cancer

Urology. 2002 Nov;60(5):913-8. doi: 10.1016/s0090-4295(02)01892-7.

Abstract

Objectives: To investigate the effects of homozygous deletions of GSTM1 and GSTT1 and smoking on bladder cancer, we conducted a case-control and ecological study.

Methods: The case group consisted of 216 patients with bladder cancer and the control group of 449 healthy Koreans. Every subject was personally interviewed to obtain a detailed smoking history, and a multiplex polymerase chain reaction method was used to detect the presence or absence of the GSTM1 and GSTT1 genes. In the ecological study, age-standardized bladder cancer incidence and frequencies of GSTM1 and GSTT1-null types, estimated prevalence of cigarette smoking, and estimated per capita consumption of cigarettes per adult according to nationality and ethnicity were included.

Results: In the Korean case-control data, smoking history and the GSTT1-null genotype were significantly associated with bladder cancer, and the GSTM1-null genotype was not. In the univariate and multivariate analyses with the ecological data of various countries and ethnic groups, cigarette smoking positively, but the frequency of the GSTT1-null type negatively, correlated with the age-standardized bladder cancer incidence.

Conclusions: These results suggest that the GSTT1-negative genotype might not be a risk factor but a protective factor of bladder cancer.

MeSH terms

  • Analysis of Variance
  • Carcinoma, Transitional Cell / ethnology
  • Carcinoma, Transitional Cell / genetics*
  • Case-Control Studies
  • Confidence Intervals
  • Female
  • Gene Deletion*
  • Genotype
  • Glutathione Transferase / genetics*
  • Humans
  • Korea
  • Male
  • Middle Aged
  • Odds Ratio
  • Risk
  • Smoking / adverse effects*
  • Urinary Bladder Neoplasms / ethnology
  • Urinary Bladder Neoplasms / genetics*

Substances

  • glutathione S-transferase T1
  • Glutathione Transferase
  • glutathione S-transferase M1